Artificial Intelligence is helping doctors diagnose more and more syndromes that were previously hard to diagnose.


Interested in the Exponential Future? Connect, download a free E-Book, watch a keynote, or browse my blog.

Artificial Intelligence (AI) is increasingly becoming a powerful new tool in the fight to properly identify, diagnose, and then treat a wide range of health problems, from the onset of dementia, depression, and PTSD, through to the diagnosis of many diseases, including eye disease, genetic diseases, heart disease, lung cancer, and even pancreatic and skin cancer with just a smartphone. And now, in yet another breakthrough a team of researchers from Cincinnati Children’s Hospital Medical Center in the US have used AI to predict Attention Deficit Hyperactivity Disorder (ADHD) in patients by having it analyse Magnetic Resonance Imaging (MRI) scans. According to a new paper published in the journal Radiology: Artificial Intelligence, their technique could also be used to spot other neurological conditions.


An AI designed 30,000 drugs in 21 days and came up with winners


Health care professionals have increasingly been relying on MRI scans to understand ADHD, a brain disorder that often causes patients to be restless, and makes it more difficult for them to pay attention. More than eight percent of children in the US have been diagnosed with the condition according to The American Psychiatric Association (APA).

Research suggests that a breakdown in the connections between the different regions of the brain, the so-called connectome, causes ADHD. MRI scans are able to spot any disruption in this network — but recogniSing the patterns that could indicate a case of ADHD is much more difficult.


US military genetics program to turn marine life into giant living sensor networks


The researchers developed a method using a deep learning model that can analyse multiple connectome maps from different regions of the brain. Their model “improved ADHD detection performance considerably” while analysing a data set of 973 participants according to the paper.

“This model can be generalised to other neurological deficiencies,” said senior author Lili He in a statement. “We already use it to predict cognitive deficiency in pre-term infants. We scan them soon after birth to predict neuro-developmental outcomes at two years of age.”

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.

Your email address will not be published. Required fields are marked *